Company · CIK 2044950
Bambusa Therapeutics, Inc.
| CIK | 2044950 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2836 — Biological Products, (No Diagnostic Substances) |
| Incorporated in | DE |
| Business address | MA |
| Listed | no ticker on SEC record today |
| First annual or quarterly report | none on EDGAR |
Offerings
1 registration| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-299405 | 2026-10-09 | 2026-10-09 | 1 |
Filings
2| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2026-10-09 | S-1Registration filed | 333-299405 | 0001628280-26-065557 |
| 2026-08-03 | DRSDraft made public | 377-09638 | 0001628280-26-051869 |